Table 1.

Expression of SLAMF receptors on myeloid lineages in SLE patients and healthy controls

	SLE patients mean ± SEM (n)	Controls mean ± SEM (n)
CD48 (SLAMF2)
Monocytes (MEF)	1180 ± 88 (37)	1105 ± 76 (27)
CD244 (SLAMF4)
Monocytes (MEF)	13,547 ± 1464 (37)	17,522 ± 1775 (27)
Eosinophils (MEF)	14,751 ± 1510 (29)	12,253 ± 1176 (27)
Platelets (MEF)	1471 ± 135 (37)	2034 ± 183 (27)
CD84 (SLAMF5)
PMNS (%)	33.9 ± 3.6 (39)	31.6 ± 4.0 (29)
Monocytes (MEF)	1509 ± 137 (35)	1555 ± 203 (25)
Eosinophils (MEF)	745 ± 67 (27)	740 ± 105 (25)
Platelets (MEF)	841 ± 78 (35)	1087 ± 102 (25)
CD352 (SLAMF6, NTB-A)
Eosinophils (MEF)	2262 ± 326 (18)	1979 ± 235 (16)
CD319 (SLAMF7, CRACC, CS1)
Monocytes (MEF)	460 ± 152 (37)	309 ± 47 (27)

MEF mean equivalent of fluorochrome, SEM standard error of the mean, n number of individuals